Brooks Laboratories Limited - Company Profile

Q: Who are the current directors of Brooks Laboratories Limited?

The current directors of Brooks Laboratories Limited are Bhushan Singh Rana, Prashant Rathi, Jitendrapratap Rambahadur Singh, Durga Shankar Maity, Usha Singh, Manav Mahajan, Lalit Mahajan.

It is a pharma public limited company based in Nalagarh, Himachal Pradesh, India, established in 2002.

2002 Nalagarh, Himachal Pradesh, India Active

Last Updated: December 21, 2025

Access Report

About Brooks Laboratories Limited

Brooks Laboratories Limited, a active public limited company, was established on 23 January 2002 in Nalagarh, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24232HP2002PLC000267. Registered under ROC Roc Himachal Pradesh. it is listed on BSE: 533543 and NSE: BROOKS. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹29.46 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹80.44 Cr and a net worth of ₹69.53 Cr. Employing 289 professional, Its leadership includes Bhushan Singh Rana (Whole-Time Director), Jitendrapratap Rambahadur Singh (Whole-Time Director), Durga Shankar Maity (Whole-Time Director). Past directors included Monika Sabharwal, Vivek Sharma, Anil Khanna. It holds ₹75.81 Cr open charges and ₹115.74 Cr settled loans. Its latest AGM occurred on 19 September 2024, with the balance sheet filed on 31 March 2024. It is based at Village Kishanpura Nalagarh Road, Baddi, Nalagarh, Himachal Pradesh, 174101.

Company Details

CIN/LLPIN
L24232HP2002PLC000267
Registration Number
000267
Incorporation Date
23 January 2002
Authorized Capital
₹30.00 Cr
Paid-Up Capital
₹29.46 Cr
ROC Code
Roc Himachal Pradesh
Listing Status
Listed (BSE: 533543, NSE: BROOKS)
Company Status
Active

Key Metrics

Authorised Capital ₹ 30.00 Cr as on 21-12-2025
Paid Up Capital ₹ 29.46 Cr as on 21-12-2025
Company Age 24 Year, 1 Month
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 75.81 Cr as on 21-12-2025
Satisfied Charges ₹ 115.74 Cr as on 21-12-2025
Revenue Growth **** 44.56% (FY 2024)
Profit Growth **** 118.66% (FY 2024)
Ebitda **** 155.33% (FY 2024)
Net Worth 22.46% (FY 2024)
Total Assets **** 2.13% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Brooks Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Brooks Laboratories Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bhushan Singh Rana	Whole-Time Director	23 Aug 2023	Current
Jitendrapratap Rambahadur Singh	Whole-Time Director	23 Nov 2022	Current
Durga Shankar Maity	Whole-Time Director	07 Jul 2023	Current
Usha Singh	Director	07 Aug 2024	Current
Manav Mahajan	Director	28 Sep 2024	Current
Lalit Mahajan	Director	07 Aug 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	06 Jan 2012	Past
Pramod Abcsdd	Director	06 Jan 2012	Past
Pramod Abcsdd	Director	02 Apr 2013	Past
Pramod Abcsdd	Director	29 Sep 2014	Past
Pramod Abcsdd	Additional Director	20 Sep 2023	Past
Pramod Abcsdd	Whole-Time Director	03 Sep 2021	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Brooks Laboratories.

Brooks Laboratories Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 44.56% increase. The company also saw a substantial improvement in profitability, with a 118.66% increase in profit. The company's net worth Soared by an impressive increase of 22.46%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

44.56%

*******

Revenue from Operations

*******

43.12%

*******

Total Assets

*******

2.13%

*******

Profit or Loss

*******

118.66%

*******

Net Worth

*******

22.46%

*******

EBITDA

*******

155.33%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Brooks Laboratories?

In 2024, Brooks Laboratories had a promoter holding of 63.59% and a public holding of 36.41%. The company had 1 Joint Venture and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹758,099,129.00

Satisfied Charges

₹1,157,357,000.00

Charges Breakdown by Lending Institutions

Others : 75.81 Cr

Latest Charge Details

Date	Lender	Amount	Status
19 Dec 2024	Others	₹63.62 Cr	Open
30 Jun 2024	Others	₹0.97 M	Open
19 Apr 2024	Others	₹0.90 M	Open
30 Oct 2014	Others	₹12.00 Cr	Open
25 Mar 2021	Indian Bank	₹19.39 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Brooks Laboratories?

Brooks Laboratories has a workforce of 289 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Brooks Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brooks Laboratories's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Brooks Laboratories

Recent Activity within the Organization

Charges

Progress on A charge registered on 25 Mar 2021 via Charge ID 100444147 with Indian Bank was fully satisfied on 31 Dec 2024. was documented.
31 Dec 2024
Charges

The activity A charge with Others amounted to Rs. 63.62 Cr with Charge ID 101043257 was registered on 19 Dec 2024. was completed.
19 Dec 2024
Director Appointment

Manav Mahajan was appointed as a Director was appointed as a Director on 28 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
28 Sep 2024
Annual General Meeting

Progress on Brooks Laboratories Limited last Annual general meeting of members was held on 19 Sep 2024 as per latest MCA records. was documented.
19 Sep 2024
Charges

The activity A charge with Others of Rs. 12.00 Cr registered on 30 Oct 2014 with Charge ID 10538996 was modified on 05 Sep 2024. was completed.
05 Sep 2024
Director Appointment

Progress on Usha Singh was appointed as a Director was appointed as a Director on 07 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.
07 Aug 2024

Explore recent activity and updates - View Recent Activity